bioRxiv · 10.1101/321208
Versatile in vivo genome editing with the prototypical Streptococcus thermophilus CRISPR1-Cas9 system
Abstract
Targeting definite genomic locations using CRISPR-Cas systems requires a set of enzymes with unique protospacer adjacent motif (PAM) compatibilities. To expand this repertoire, we engineered nucleases, cytosine base editors, and adenine base editors from the archetypal Streptococcus thermophilus CRISPR1-Cas9 (St1Cas9) system. We found that St1Cas9 strain variants enable targeting to five distinct A-rich PAMs and provide structural basis for their specificities. The small size of this ortholog enables expression of the holoenzyme from a single adeno-associated viral vector for in vivo editing applications. Delivery of St1Cas9 to the neonatal liver efficiently rewired metabolic pathways, leading to phenotypic rescue in a mouse model of hereditary tyrosinemia. These robust enzymes expand and complement current editing platforms available for tailoring mammalian genomes.
Source connections
Explore related subjects
Keep this discovery
Carter, S., Agudelo, D., Duringer, A., Loehr, J., Doyon, Y.. 2018-05-14. Versatile in vivo genome editing with the prototypical Streptococcus thermophilus CRISPR1-Cas9 system. https://doi.org/10.1101/321208
Cite the original work for its findings. Save a collection to share your selection of sources.